Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis
- PMID: 23093980
- PMCID: PMC3474991
- DOI: 10.1155/2012/959061
Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis
Abstract
Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten in genetically susceptible individuals. Gluten is a protein component in wheat and other cereals like rye and barley. At present, the only available treatment is a strict gluten-free diet. Recent advances have increased our understanding of the molecular basis for this disorder. Last decade has seen new scientific developments in this disease and led to the formulation of new concepts of pathophysiology that offer possible targets for new treatments or interventions integrative to the gluten-free diet.
Figures
References
-
- Högberg L, Fälth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scandinavian Journal of Gastroenterology. 2003;38(1):61–65. - PubMed
-
- Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119(1):234–242. - PubMed
-
- Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. The Lancet. 2000;355(9214):1518–1519. - PubMed
-
- Byrne S, Cooper Z, Fairburn C. Weight maintenance and relapse in obesity: a qualitative study. International Journal of Obesity. 2003;27(8):955–962. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
